Other selected research from the 'Business Development' category:
The US Pharmaceutical Market 2009-2024
what will happen next in the world’s largest pharma market? Our new market study explains, letting you know the implications of change. - Including over 65 tables, graphs and figures Learn More
World Vaccines Market 2011-2021
see which market areas will grow fastest Do you want to know how the vaccines industry and market will develop from 2011? Our new report shows you potential revenues to... Learn More
Other selected research from the 'Marketing & Sales' category:
Analytical Tool
The Global OTC Pharmaceutical Market 2009-2024
OTC pharma is influenced by changes in consumer spending - but significant commercial opportunities for OTC switching will drive market expansion worldwide. Learn More
Other selected research from the 'Analytical Tool' category:
Analytical Tool - Cancer Therapeutic Antibodies
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer antibody R&D and business development. Learn More
Analytical Tool - Peptides in Oncology
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer peptide R&D and business development. Learn More
Other selected research from the 'Drug Pipeline Updates' category:
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2012
BioSeeker Group have identified 187 companies plus partners who are today developing 245 IL-2 pathway targeting drugs in 698 developmental projects in cancer across 127 different targets. In addition, there are 4 suspended drugs and another 104 drugs where development has been ceased. Learn More
Neuroendocrine Tumors Drug Pipeline Update 2012
BioSeeker Group have identified 50 companies plus partners who are today developing 60 neuroendocrine tumor drugs in 83 developmental projects in cancer across 54 different targets. In addition, another 5 drugs where development has been ceased. Learn More
Other selected research from the 'Therapeutics' category:
Market for Rx to OTC Switches, The
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the counter drugs are widely anticipated to grow as consumers seek cheaper alternatives... Learn More
Antibiotic Resistance 2012: The Antibiotics Development Pipeline and Strategies to Combat Antibiotic Resistance
This report gives a comprehensive overview of global antibiotic resistance, the antibiotics pipeline and new strategies to target resistance mechanisms. It identifies 109 antibiotics in the development pipeline, approximately 70... Learn More
Other selected research from the 'Oncology' category:
Triple Analysis: Breast Cancer, Leukemia and Peptides
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Leukemia and by the compound strategy of Peptides. Learn More
Triple Analysis: Breast Cancer, Colorectal Cancer and Apoptosis
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the mechanism/target/effect of Apoptosis. Learn More
Other selected research from the 'Markets' category:
Osteoporosis & Bone Metabolism Disorders Market 2008-2023 Management Report
In 2007, the world market for bone metabolism disorder pharmaceuticals generated sales of over $10bn - how much of this market have you captured? Learn More
The Japanese Pharmaceutical Market 2008-2023
This report examines Japanese pharmaceutical market critically, through a comprehensive review of available information. Sources include in-depth interviews, primary research, industrial databases, commercial news, in-house reports and economic research. Learn More